Clicky

Galapagos NV(GLPG) News

Date Title
Feb 24 Galapagos to Present at Upcoming Investor Conferences
Feb 18 Galapagos (AMS:GLPG) adds €185m to market cap in the past 7 days, though investors from five years ago are still down 89%
Feb 17 Galapagos receives transparency notification and 13D filing from Tang Capital
Feb 5 Galapagos (GLPG) Loses -21.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Sep 30 Galapagos receives transparency notification from EcoR1 Capital
Jun 14 Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
Jun 14 Retail investors are Galapagos NV's (AMS:GLPG) biggest owners and were hit after market cap dropped €74m
May 15 Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
May 6 Galapagos NV (NASDAQ:GLPG) Q1 2024 Earnings Call Transcript
May 4 Galapagos First Quarter 2024 Earnings: EPS: €0.36 (vs €0.35 in 1Q 2023)
May 2 Galapagos reports first quarter 2024 financial results
Apr 30 Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024
Apr 24 Down -9.97% in 4 Weeks, Here's Why You Should You Buy the Dip in Galapagos (GLPG)
Apr 4 Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
Apr 3 After Plunging -7.94% in 4 Weeks, Here's Why the Trend Might Reverse for Galapagos (GLPG)
Mar 28 Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
Mar 26 Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
Mar 18 Down -14.35% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround
Mar 17 11 Oversold Biotech Stocks To Buy Right Now
Jan 2 Galapagos signs agreement to transfer Jyseleca® business to Alfasigma